Abstract
Glycosphingolipids (GSLs) are a specialized class of membrane lipids composed of a ceramide and a carbohydrate head group. GSLs are localized in cell membranes and were recently found to be enriched in the membrane of neuron-derived exosomes, which are a type of extracellular vesicle. Our studies demonstrated that exosomal GSLs may be associated with the amyloid-ß (Aß) peptide, a principal agent of Alzheimer’s disease (AD), and act to clear Aß by transporting Aß into brain phagocytic microglia. In this review, we summarize and discuss the function of exosomal GSLs in Aß homeostasis in AD pathology. Improvement in Aß clearance is a potent strategy for AD prevention and therapy. Dietary glucosylceramides (GlcCer) isolated from plants are absorbed into the body as various metabolites, including ceramides. Our recent work demonstrated that dietary GlcCer accelerates neuronal exosome production, which facilitates Aß clearance in mice. Furthermore, studies of AD model mice and human clinical trials have found that oral administration of plant-type GlcCer attenuates the Aß burden in the brain. We also introduce the development of plant-type GlcCer as functional food materials to prevent AD.
Similar content being viewed by others
References
Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Beyreuther, K.: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82(12), 4245–4249 (1985)
Kosik, K.S., Joachim, C.L., Selkoe, D.J.: Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. USA 83(11), 4044–4048 (1986)
Hardy, J., Selkoe, D.J.: The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580), 353–356 (2002)
Rajendran, L., Annaert, W.: Membrane trafficking pathways in Alzheimer’s disease. Traffic 13(6), 759–770 (2021)
Mawuenyega, K.G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J.C., Yarasheski, K.E., Bateman, R.J.: Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330(6012), 1774 (2010)
Hipp, M.S., Kasturi, P., Hartl, F.U.: The proteostasis network and its decline in ageing. Nat. Rev. Mol. Cell Biol. 20(7), 421–435 (2019)
Nedergaard, M., Goldman, S.A.: Glymphatic failure as a final common pathway to dementia. Science 370(6512), 50–56 (2020)
Jeremic, D., Jiménez-Díaz, L., Navarro-López, J.D.: Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Res. Rev. 72, 101496 (2021)
Rajendran, L., Honsho, M., Zahn, T.R., Keller, P., Geiger, K.D., Verkade, P., Simons, K.: Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. USA 103(30), 11172–11177 (2006)
Simons, M., Raposo, G.: Exosomes–vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21(4), 575–581 (2009)
Fauré, J., Lachenal, G., Court, M., Hirrlinger, J., Chatellard-Causse, C., Blot, B., Grange, J., Schoehn, G., Goldberg, Y., Boyer, V., Kirchhoff, F., Raposo, G., Garin, J., Sadoul, R.: Exosomes are released by cultured cortical neurons Mol. Cell Neurosci. 231(4), 642–648 (2006)
Cataldo, A.M., Barnett, J.L., Pieroni, C., Nixon, R.A.: Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci. 17(16), 6142–6151 (1997)
Cataldo, A.M., Rebeck, G.W., Ghetri, B., Hulette, C., Lippa, C., van Broeckhoven, C., van Duijn, C., Cras, P., Bogdanovic, N., Bird, T., Peterhoff, C., Nixon, R.A.: Endocytic disturbances distinguish among subtypes of Alzheimer’s disease and related disorders. Ann Neurol. 50(5), 661–665 (2001)
Takahashi, R.H., Milner, T.A., Li, F., Nam, E.E., Edgar, M.A., Yamaguchi, H., Beal, M.F., Xu, H., Greengard, P., Gouras, G.K.: Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Phys. Anthropol. 161(5), 1869–1879 (2002)
Langui, D., Girardot, N., Hachimi, E.K.H., Allinquant, B., Blanchard, V., Pradier, L., Duyckaerts, C.: Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice. Am. J. Pathol. 165(5), 1465–1477 (2010)
Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Tahara, H., Furukawa, J.I., Fujitani, N., Shinohara, Y., Igarashi, Y.: Decreased amyloid-β pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J. Biol. Chem. 289(35), 24488–24498 (2014)
Yuyama, K., Sun, H., Usuki, S., Sakai, S., Hanamatsu, H., Mioka, T., Kimura, N., Okada, M., Tahara, H., Furukawa, J.I., Fujitani, N., Shinohara, Y., Igarashi, Y.: A potential function for neuronal exosomes: sequestering intracerebral amyloid-β peptide. FEBS Lett. 589(1), 84–88 (2015)
Yanagisawa, K., Odaka, A., Suzuki, N., Ihara, Y.: GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer’s disease Nat. Med. 1(10), 1062–1066 (1995)
Ariga, T., McDonald, M.P., Yu, R.K.: Role of ganglioside metabolism in the pathogenesis of Alzheimer’s disease–a review. J. Lipid Res. 49(6), 1157–1175 (2008)
Yamamoto, N., Matsubara, T., Sato, T., Yanagisawa, K.: Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis. Biochim. Biophys. Acta. 1778(12), 2717–2726 (2008)
Hong, S., Ostaszewski, B.L., Yang, T., O’Malley, T.T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., Selkoe, D.J.: Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes Neuron 82(2), 308–319 (2014)
Grey, M., Dunning, C.J., Gaspar, R., Grey, C., Brundin, P., Sparr, E., Linse, S.: Acceleration of α-synuclein aggregation by exosomes. J. Biol. Chem. 290(5), 2969–2682 (2015)
Gaspar, R., Pallbo, J., Weininger, U., Linse, S., Sparr, E.: Ganglioside lipids accelerate α-synuclein amyloid formation. Biochim. Biophys. Acta Proteins Proteom. 1866(10), 1062–1072 (2018)
Green, D.R., Oguin, T.H., Martinez, J.: The clearance of dying cells: table for two. Cell Death Differ. 23(6), 915–926 (2016)
Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T.A., Guiducci, E., Dumas, L., Ragozzino, D., Gross, C.T.: Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048), 1456–1458 (2011)
Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., Regen, T., Hanisch, U.-K., Simons, M.: Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124(Pt 3), 447–458 (2011)
Yuyama, K., Sun, H., Mitsutake, S., Igarashi, Y.: Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia. J. Biol. Chem. 287(14), 10977–10989 (2012)
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., Simons, M.: Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319(5867), 1244–1247 (2008)
Vietri, M., Radulovic, M., Stenmark, H.: The many functions of ESCRTs Nat. Rev. Mol. Cell Biol. 21(1), 25–42 (2019)
Yuyama, K., Sun, H., Mikami, D., Mioka, T., Mukai, K., Igarashi, Y.: Lysosomal-associated transmembrane protein 4B regulates ceramide-induced exosome release. FASEB J. 34(12), 16022–16033 (2020)
Shao, G.-Z., Zhou, R.-L., Zhang, Q.-Y., Zhang, Y., Liu, J.-J., Rui, J.-A., Wei, X., Ye, D.-X.: Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma Oncogene 22(32), 5060–5069 (2003)
Zhou, K., Dichlberger, A., Martinez-Seara, H., Nyholm, T.K.M., Li, S., Kim, Y.A., Vattulainen, I., Ikonen, E., Blom, T.: A Ceramide-Regulated Element in the Late Endosomal Protein LAPTM4B Controls Amino Acid Transporter Interaction ACS Cent. Sci. 4(5), 548–558 (2018)
Kajimoto, T., Okada, T., Miya, S., Zhang, L., Nakamura, S.-I.: Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes. Nat. Commun. 4, 2712 (2013)
Sugawara, T., Aida, K., Duan, J., Hirata, T.: Analysis of glucosylceramides from various sources by liquid chromatography-ion trap mass spectrometry. J. Oleo Sci. 59(7), 387–394 (2010)
Eguchi, K., Mikami, D., Sun, H., Tsumita, T., Takahashi, K., Mukai, K., Yuyama, K., Igarashi, Y.: Blood-brain barrier permeability analysis of plant ceramides. PLoS ONE 15(11), e0241640 (2020)
Yunoki, K., Ogawa, T., Ono, J., Miyashita, R., Aida, K., Oda, Y., Ohnishi, M.: Analysis of sphingolipid classes and their contents in meals Biosci. Biotechnol. Biochem. 72(1), 222–225 (2008)
Nilsson, A.: Metabolism of cerebroside in the intestinal tract of the rat Biochim. Biophys. Acta. 187(1), 113–121 (1969)
Schmelz, E.M., Crall, K.J., Larocque, R., Dillehay, D.L., Merrill, A.H.: Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J. Nutr. 124(5), 702–712 (1994)
Ishikawa, J., Takada, S., Hashizume, K., Takagi, Y., Hotta, M., Masukawa, Y., Kitahara, T., Mizutani, Y., Igarashi, Y.: Dietary glucosylceramide is absorbed into the lymph and increases levels of epidermal sphingolipids. J. Dermatol. Sci. 56(3), 220–222 (2009)
Mikami, D., Sakai, S., Nishimukai, M., Yuyama, K., Mukai, K., Igarashi, Y.: Structure-dependent absorption of atypical sphingoid long-chain bases from digestive tract into lymph. Lipids Health Dis. 20(1), 24 (2021)
Hasegawa, T., Shimada, H., Uchiyama, T., Ueda, O., Nakashima, M., Matsuoka, Y.: Dietary glucosylceramide enhances cornified envelope formation via transglutaminase expression and involucrin production. Lipids 46(6), 529–535 (2011)
Tsuji, K., Mitsutake, S., Ishikawa, J., Takagi, Y., Akiyama, M., Shimizu, H., Tomiyama, T., Igarashi, Y.: Dietary glucosylceramide improves skin barrier function in hairless mice. J. Dermatol. Sci. 44(2), 101–107 (2006)
Miyanishi, K., Shiono, N., Shirai, H., Dombo, M., Kimata, H.: Reduction of transepidermal water loss by oral intake of glucosylceramides in patients with atopic eczema. Allergy 60(11), 1454–1455 (2005)
Duan, R.-D., Nilsson, Å.: Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog Lipid Res. 48(1), 62–72 (2009)
Yuyama, K., Takahashi, K., Usuki, S., Mikami, D., Sun, H., Hanamatsu, H., Furukawa, J.I., Mukai, K., Igarashi, Y.: Plant sphingolipids promote extracellular vesicle release and alleviate amyloid-β pathologies in a mouse model of Alzheimer’s disease. Sci Rep. 9(1), 16827–16911 (2019)
Shirakura, Y., Kikuchi, K., Matsumura, K., Mukai, K., Mitsutake, S., Igarashi, Y.: 4,8-Sphingadienine and 4-hydroxy-8-sphingenine activate ceramide production in the skin. Lipids Health Dis. 11(1), 108 (2012)
Sigruener, A., Tarabin, V., Paragh, G., Liebisch, G., Koehler, T., Farwick, M., Schmitz, G.: Effects of sphingoid bases on the sphingolipidome in early keratinocyte differentiation Exp. Dermatol. 22(10), 677–679 (2013)
Hong, S., Beja-Glasser, V.F., Nfonoyim, B.M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K.M., Shi, Q., Rosenthal, A., Barres, B.A., Lemere, C.A., Selkoe, D.J., Stevens, B.: Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286), 712–716 (2016)
Wright, A.L., Zinn, R., Hohensinn, B., Konen, L.M., Beynon, S.B., Tan, R.P., Clark, I.A., Abdipranoto, A., Vissel, B.: Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease PLoS ONE 8(4), e59586 (2013)
Eguchi, K., Mukai, K., Yuyama, K., Kurimoto, N., Tanaka, A., Katsuyama, T., Nishihira, J., Monde, K., Igarashi, Y.: Attenuating Effects of Glucosylceramide Extracted from Konjac on Amyloid ß Accumulation in the Human Brains Japanese Pharm. Thera. 49(8), 1–15 (2021)
Nakamura, A., Kaneko, N., Villemagne, V.L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., Tomita, T., Matsuzaki, K., Ishii, K., Ishii, K., Arata, Y., Iwamoto, S., Ito, K., Tanaka, K., Masters, C.L., Yanagisawa, K.: High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature 554(7691), 249–254 (2018)
Janelidze, S., Teunissen, C.E., Zetterberg, H., Allué, J.A., Sarasa, L., Eichenlaub, U., Bittner, T., Ovod, V., Verberk, I.M.W., Toba, K., Nakamura, A., Bateman, R.J., Blennow, K., Hansson, O.: Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease. JAMA Neurol. 78(11), 1375–1382 (2021)
He, X., Huang, Y., Li, B., Gong, C.X., Schuchman, E.H.: Deregulation of sphingolipid metabolism in Alzheimer's disease Neurobiol Aging. 31(3), 398–408 (2010)
Mielke, M,M., Haughey, N.J., Ratnam Bandaru, V.V., Schech, S., Carrick, R., Carlson, M.C., Mori, S., Miller, M.I., Ceritoglu, C., Brown, T., Albert M., Lyketsos C.G.: Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement. 6(5), 378–385 (2010)
Bandaru, V.V., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., Haughey, N.J.: ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol. Aging 30(4), 591–599 (2009)
Han, X., Holtzman, D.M., McKeel, D.W., Kelley, J., Morris, J.C.: Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis. J Neurochem 82(4), 809–818 (2002)
Acknowledgements
This work was supported by Industry Creation Departments Funding (8607011, PCS8617001) provided by Daicel Corporation to the Lipid Biofunction Section of Hokkaido University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yuyama, K., Igarashi, Y. Linking glycosphingolipids to Alzheimer’s amyloid-ß: extracellular vesicles and functional plant materials. Glycoconj J 39, 613–618 (2022). https://doi.org/10.1007/s10719-022-10066-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-022-10066-8